Author:
Russell Danielle M.,Meyerson Beth E.,Mahoney Arlene N.,Garnett Irene,Ferrell Chris,Newgass Kylee,Agley Jon D.,Crosby Richard A.,Bentele Keith G.,Vadiei Nina,Frank David,Linde-Krieger Linnea B.
Abstract
Abstract
Background
Pharmacies are critical healthcare partners in community efforts to eliminate bloodborne illnesses. Pharmacy sale of sterile syringes is central to this effort.
Methods
A mixed methods “secret shopper” syringe purchase study was conducted in the fall of 2022 with 38 community pharmacies in Maricopa and Pima Counties, Arizona. Pharmacies were geomapped to within 2 miles of areas identified as having a potentially high volume of illicit drug commerce. Daytime venue sampling was used whereby separate investigators with lived/living drug use experience attempted to purchase syringes without a prescription. Investigator response when prompted for purchase rationale was “to protect myself from HIV and hepatitis C.” A 24-item instrument measured sales outcome, pharmacy staff interaction (hostile/neutral/friendly), and the buyer’s subjective experience.
Results
Only 24.6% (n = 28) of 114 purchase attempts across the 38 pharmacies resulted in syringe sale. Less than one quarter (21.1%) of pharmacies always sold, while 44.7% never sold. Independent and food store pharmacies tended not to sell syringes. There emerged distinct pharmacy staff interactions characterized by body language, customer query, normalization or othering response, response to purchase request and closure. Pharmacy discretion and pharmacy policy not to sell syringes without a prescription limited sterile syringe access. Investigators reported frequent and adverse emotional impact due to pharmacy staff negative and stigmatizing interactions.
Conclusions
Pharmacies miss opportunities to advance efforts to eliminate bloodborne infections by stringent no-sale policy and discretion about syringe sale. State regulatory policy facilitating pharmacy syringe sales, limiting pharmacist discretion for syringe sales, and targeting pharmacy-staff level education may help advance the achievement of public health goals to eliminate bloodborne infections in Arizona.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. National Institutes of Health. 10 percent of US adults have drug use disorder at some point in their lives. November 18, 2015. [Online] Available from: https://www.nih.gov/news-events/news-releases/10-percent-us-adults-have-drug-use-disorder-some-point-their-lives. Accessed 11 May 2023.
2. Chan Carusone S, Guta A, Robinson S, et al. “Maybe if I stop the drugs, then maybe they’d care?”—Hospital care experiences of people who use drugs. Harm Reduct J. 2019;16(1):1–10. https://doi.org/10.1186/s12954-019-0285-7.
3. Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don’t even want to go to the doctor when I get sick now: healthcare experiences and discrimination reported by People Who Use Drugs, Arizona 2019. Int J Drug Policy. 2021;93:103–12. https://doi.org/10.1016/j.drugpo.2021.103112.
4. Surratt HL, Otachi JK, McLouth CJ, Vundi N. Healthcare stigma and HIV risk among rural people who inject drugs. Drug Alcohol Depend. 2021;226:1–21. https://doi.org/10.1016/j.drugalcdep.2021.108878.
5. Farrugia A, Pienaar K, Fraser S, Edwards M, Madden A. Basic care as exceptional care: addiction stigma and consumer accounts of Quality Healthcare in Australia. Health Sociol Rev. 2020;30(2):95–110. https://doi.org/10.1080/14461242.2020.1789485.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献